Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.34 |
| ▸ | KDM4A | O75164 | 1/20 | 0.34 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.34 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.34 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | BHMT | Q93088 | 2/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4388239 | 0.99 | ALDH1A1 (0.38) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4388242 | 0.99 | ALDH1A1 (0.38) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4386107 | 0.99 | ALDH1A1 (0.38) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4395469 | 0.99 | ALDH1A1 (0.38) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4384284 | 0.99 | ALDH1A1 (0.38) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4384337 | 0.95 | TSHR (0.37) | TSHRALDH1A1GSTK1ADRA1ABHMT | |
| SCHEMBL4395402 | 0.89 | FFAR4 (0.36) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4387909 | 0.87 | FFAR4 (0.39) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4388748 | 0.87 | FFAR4 (0.39) | TSHRALDH1A1FFAR4FFAR1KDM4C | |
| SCHEMBL4388297 | 0.87 | FFAR4 (0.39) | TSHRALDH1A1FFAR4FFAR1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629383-B2 | Double esters | DRUG DISCOVERY LABORATORY AS (NO) | 2009-12-08 | — | — | US | disclosed |
| US-20050203181-A1 | Double esters | DRUG DISCOVERY LABORATORY AS (NO) | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203181-A1 | Double esters | ACACA, CES1, ACACB | TSHR 1933/4885ALDH1A1 296/4885FFAR4 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.